63 completed, 28 unknown, 15 recruiting, 3 terminated. 33 Not applicable, 14 Phase 1, 9 Phase 2, 5 Phase 4, 4 Phase 3.
Follow Infectious Disease: new trials by email Literature Review of Infectious Disease trials Research Report on Infectious Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vitality in Infants Via Azithromycin for Neonates Trial Azithromycin at Baseline, Azithromycin at Day 21, Placebo at Baseline - Neonatal Death, Infectious Disease | Phase 4 | Not yet recruiting | University of California, San Francisco | 4000 | 2026-04-01 | 2025-08-29 |
| L-citrulline to Improve Adverse Outcomes in Admitted Children (EChiLiBRiST, Clinical Trial 2, Inpatients) L-citrulline, Placebo - Infectious Disease, Infections | Not applicable | Recruiting | Barcelona Institute for Global Health | 2200 | 2025-12-08 | 2026-02-23 |
| An International Observational Study of Adults With Acute Infection No intervention - Infectious Disease | Recruiting | University of Minnesota | 1500 | 2025-08-25 | 2026-08-27 | |
| A Rapid Triage Test to Improve Risk-stratification of Febrile Children (EChiLiBRiST, Clinical Trial 1, Outpatients) IMCI-enhanced by suPAR levels (SoC + suPAR POC) - Infectious Disease, Febrile Illness | Not applicable | Recruiting | Barcelona Institute for Global Health | 5212 | 2025-07-02 | 2026-07-28 |
| Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial genotype-directed dosing with dosing software based on therapeutic drug monitoring - Fungal Infection, Haematological Malignancy | Phase 2 | Recruiting | The University of Queensland | 104 | 2025-04-14 | 2026-04-16 |
| Rickettsia Clearance Study Doxycyclin, Azithromycin - Infectious Disease, Therapeutics | Phase 2 / Phase 3 | Recruiting | Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit | 72 | 2024-11-01 | 2026-10-13 |
| A Phase 1 Study to Evaluate JCXH-108, an mRNA-based Vaccine Against RSV JCXH-108, Placebo - Respiratory Syncytial Virus (RSV), Infectious Disease | Phase 1 | Active not recruiting | Immorna Biotherapeutics, Inc. | 75 | 2024-09-25 | 2026-04-23 |
| A Single-Dose, Three-Way, Three-Sequence, Crossover BA Study of Azithromycin Oleogel Azithromycin Oleogel (Oral and Rectal) - Infectious Disease, Drug Effect | Phase 1 | Completed | Brigham and Women's Hospital | 18 | 2024-08-08 | 2026-02-04 |
| Triage Survey for Infectious Disease Eligibility Vaccination; Infection, HIV-1-infection | Recruiting | Brooklyn Clinical Research | 10000 | 2024-06-28 | 2024-07-09 | |
| Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection Start Antibiotics / Continue Antibiotics for treatment of bacteriuria, No Antibiotics for treatment of bacteriuria - Infectious Disease | Not applicable | Recruiting | Mount Sinai Hospital, Canada | 550 | 2024-05-18 | 2024-09-19 |
| Evaluation of Tolerance and Pharmacokinetic Profile of High Doses of Favipiravir in Healthy Volunteers favipiravir, Placebo - Infectious Disease, Pharmacology | Phase 1 | Recruiting | Institut National de la Santé Et de la Recherche Médicale, France | 39 | 2024-05-14 | 2026-02-12 |
| Contribution of a Video Support to Inform the Patient Before a Complementary Examination in Infectious Diseases Oral and written information, Video information - Infectious Disease | Completed | Assistance Publique - Hôpitaux de Paris | 97 | 2023-12-15 | 2026-03-27 | |
| Prevalence and Associated Mortality of Infections by Multidrug-Resistant Organisms in Adults Intensive Care Units Observation and collecting data - Infectious Disease | Completed | Hospital Italiano de Buenos Aires | 1799 | 2023-11-24 | 2024-08-28 | |
| Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects RQ-001, Placebo - COVID-19, Infectious Disease | Phase 1 | Completed | Red Queen Therapeutics, Inc. | 66 | 2023-09-27 | 2024-01-11 |
| A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression Tafenoquine Oral Tablet, Placebo - COVID 19 Disease, Mild to Moderate COVID 19 Disease | Phase 2 | Unknown | 60P Australia Pty Ltd | 148 | 2023-08-01 | 2023-07-17 |
| Pilot Clinical Trial - Comparative Study of Two Material Concentration of OD-141309 Antimicrobial efficacy of gel ZHCK4 as a patient preoperative skin preparation - Infectious Disease | Early Phase 1 | Unknown | Zaycor Healthcare Corp | 84 | 2023-06-01 | 2022-02-11 |
| A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster Vaccine JCXH-105, Active Control (Shingrix) - Herpes Zoster (HZ), Shingles | Phase 1 | Completed | Immorna Biotherapeutics, Inc. | 75 | 2023-05-26 | 2024-09-19 |
| AUD Biomarkers Study (Proteomic and Genomic Analysis of Biospecimens) Observational Study Only. NO Intervention. - Oncology, Hematologic Malignancy | Enrolling by invitation | Audubon Bioscience | 10000 | 2023-05-10 | 2023-06-05 | |
| Safety & Immunogenicity of RVM-V001/RVM-V002 or RVMV001+RVMV002 (Co Administered as Separate Injections) in Healthy Individuals RVM-V001 30 µg, RVM-V002 30 µg, RVM-V001 (15 µg) + RVM-V002 (15 µg) co-administration - Infectious Disease, COVID-19 | Phase 1 / Phase 2 | Terminated | RVAC Medicines (US), Inc. | 24 | 2023-03-22 | 2023-10-16 |
| A Phase 1 Study to Assess the Safety and Immunogenicity of JCXH-221, an MRNA-based Broadly Protective COVID-19 Vaccine JCXH-221, Placebo - COVID-19, Infectious Disease | Phase 1 | Completed | Immorna Biotherapeutics, Inc. | 73 | 2023-03-07 | 2024-09-19 |
Showing 20 of 115. Sign in to see all of them.
Communicable Diseases (115) · COVID-19 (20) · Neoplasms (9) · Pneumonia (6) · Cardiovascular Diseases (4) · Coronavirus Infections (4) · Autoimmune Diseases (3) · Infections (3) · Influenza, Human (3) · Respiration Disorders (3) · Respiratory Tract Infections (3) · Severe Acute Respiratory Syndrome (3) · Skin Diseases (3) · Urinary Tract Infections (3) · Virus Diseases (3)
Disease Attributes (115) · Pathologic Processes (115) · Pathological Conditions, Signs and Symptoms (115) · Infections (112) · Respiratory Tract Diseases (30) · Virus Diseases (29) · RNA Virus Infections (28) · Lung Diseases (25) · Respiratory Tract Infections (24) · Coronaviridae Infections (20) · Nidovirales Infections (20) · Pneumonia (19) · Pneumonia, Viral (19) · Coronavirus Infections (16) · Bacterial Infections and Mycoses (7)
Blood Specimen Collection (3) · Azithromycin (2) · RVM-V001 COVID-19 vaccine (2) · Telemedicine (2) · Watchful Waiting (2) · favipiravir (2) · hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine (2) · 13-valent pneumococcal vaccine (1) · Administration, Rectal (1) · Amoxicillin (1) · Amoxicillin-Potassium Clavulanate Combination (1) · Anti-Bacterial Agents (1) · CRV-431 (1) · Caffeine (1) · Cefazolin (1)
Brigham and Women's Hospital (3) · Immorna Biotherapeutics, Inc. (3) · Institut National de la Santé Et de la Recherche Médicale, France (3) · University of Edinburgh (3) · Assistance Publique - Hôpitaux de Paris (2) · Barcelona Institute for Global Health (2) · Beneo-Institute (2) · Changhai Hospital (2) · Children's Hospital of Fudan University (2) · ContraVir Pharmaceuticals, Inc. (2) · Ina-Respond (2) · Jiangsu Famous Medical Technology Co., Ltd. (2) · Johns Hopkins Bloomberg School of Public Health (2) · Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit (2) · Medical University of South Carolina (2)
United States (34) · France (15) · China (9) · Canada (4) · Pakistan (4) · Singapore (4) · Spain (4) · Australia (3) · India (3) · Indonesia (3) · Norway (3) · Thailand (3) · United Kingdom (3) · Argentina (2) · Austria (2)
Dr Tabish Hazir, MBBS, FRCPCH (3) · Quique Bassat, Prof (2) · Zhuan Liao, MD (2) · Abdullah Baqui (1) · Abdullah S. Ali, Manager (1) · Adam Spivak, MD (1) · Alistair Story, Phd (1) · Anna Bowen, MD, MPH (1) · Anne Salonen, PhD (1) · Avi Peretz, PhD (1)
PMID 15616839, PMID 17855683, PMID 18539225, PMID 19671016, PMID 19684100, PMID 20352087, PMID 21965811, PMID 24423245, PMID 24881497, PMID 27667330, PMID 29038184, PMID 29982534, PMID 30269072, PMID 30519584, PMID 30776899, PMID 31253623, PMID 31462437, PMID 31856304, PMID 32167489, PMID 32219428, PMID 32253318, PMID 32254064, PMID 32382733, PMID 32634589, PMID 32694043, PMID 32699166, PMID 32792417, PMID 32934372, PMID 33206054, PMID 33333292, PMID 33406353, PMID 33621405, PMID 33820486, PMID 34036552, PMID 34364096, PMID 34635529, PMID 34857814, PMID 35101449, PMID 35383374, PMID 35428213, PMID 35668841, PMID 35713893, PMID 35906015, PMID 36342104, PMID 36496395, PMID 36969244, PMID 37523315, PMID 37982612, PMID 38759580, PMID 39500494
2019 (1), K23DA039769 (1), KL2TR001429 (1), U01DA053039 (1)